Literature DB >> 25761220

The overexpression of SOX2 affects the migration of human teratocarcinoma cell line NT2/D1.

Danijela Drakulic1, Jelena Marjanovic Vicentic1, Marija Schwirtlich1, Jelena Tosic1, Aleksandar Krstic1, Andrijana Klajn1, Milena Stevanovic1.   

Abstract

The altered expression of the SOX2 transcription factor is associated with oncogenic or tumor suppressor functions in human cancers. This factor regulates the migration and invasion of different cancer cells. In this study we investigated the effect of constitutive SOX2 overexpression on the migration and adhesion capacity of embryonal teratocarcinoma NT2/D1 cells derived from a metastasis of a human testicular germ cell tumor. We detected that increased SOX2 expression changed the speed, mode and path of cell migration, but not the adhesion ability of NT2/D1 cells. Additionally, we demonstrated that SOX2 overexpression increased the expression of the tumor suppressor protein p53 and the HDM2 oncogene. Our results contribute to the better understanding of the effect of SOX2 on the behavior of tumor cells originating from a human testicular germ cell tumor. Considering that NT2/D1 cells resemble cancer stem cells in many features, our results could contribute to the elucidation of the role of SOX2 in cancer stem cells behavior and the process of metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25761220     DOI: 10.1590/0001-3765201520140352

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  2 in total

Review 1.  Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies.

Authors:  Andrijana Lazic; Vanda Balint; Danijela Stanisavljevic Ninkovic; Mina Peric; Milena Stevanovic
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

2.  Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma.

Authors:  Zhengqing Bao; Yonghao Zhan; Shiming He; Yifan Li; Bao Guan; Qun He; Xinyu Yang; Xuesong Li; Dong Fang; Liqun Zhou
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.